Finkelstein & Partners
1279 Route 300
Newburgh, NY, 12551


Review Us On Google
Finkelstein & Partners, LLP – Winning Serious Injury Lawsuits Since 1959

A mass tort is a type of civil action involving a group of plaintiffs with similar claims against one or more defendants in state or federal court. Mass torts are typically filed by individuals representing the group who have suffered physical or other injuries because of the negligence or misconduct of a corporation. Finkelstein & Partners is accepting the following cases. If you or a loved one has suffered some or all of the symptoms noted below due to Juul use/Vaping, Elmiron or Zantac, please contact us immediately.

JUUL / Vaping

We are investigating claims on behalf of individuals who have been specifically diagnosed with a Vaping-related or lung injury or who were diagnosed with one of the below injuries at or near the time of Vaping:

  • Acute respiratory, cardiac, or neurological injury.
  • Qualifying acute injuries include but are not limited to:
    • EVALI
    • Collapsed Lung
    • Bronchiolitis (“Popcorn Lung”)
    • Pulmonary Embolism
    • Acute Respiratory Distress Syndrome (ARDS)
    • Cardiac Arrest
    • Heavy Metal Poisoning (i.e. Cobalt, Cadmium, Lead)
    • Stroke
    • Seizure
    • Other neurological condition

If an individual is under the age of 25 years old, we can also help with addiction claims, and/or cases with a chronic respiratory injury (i.e. COPD, asthma),  if there is no prior long-term smoking history.  All injuries must be suffered at or near the time of vaping.


Elmiron is a drug commonly prescribed to treat interstitial cystitis and oseteoarthritis.  If you or a loved one took Elmiron for at least six months or longer and as a result experienced the below injuries, please contact us now.

  • Pigmentary Maculopathy
  • Retinal Maculopathy
  • Macular Degeneration
  • Pattern Dystrophy
  • Vision Loss / Vision Impairment
  • Visual disturbances
  • Blurred Vision
  • Blindness (unilateral or bilateral)


Zantac is one of the most widely used pharmaceuticals in the United States. Zantac decreases the amount of acid in a patient’s stomach and is often prescribed when patients are suffering from heartburn caused by acid indigestion. Physicians may also recommend Zantac to their patients for the treatment of ulcers or gastroesophageal reflux disease. Zantac has been voluntarily recalled due to the presence of NDMA (N-Nitrosodimethylamine), which is a probable carcinogen. The FDA is alerting both patients and health care providers of these recalls while also conducting additional testing to determine the levels of NDMA.

NDMA is a chemical that has been classified by the FDA (as well as the EPA and World Health organization) as carcinogen, a cancer-causing substance, based on results from laboratory tests. NDMA is a known environmental contaminant and can be found in many common sources including water and foods such as meats, dairy and vegetables.

If you have taken Zantac and have been diagnosed with any of the below cancers, you may have a potential claim against the manufacturer:

  • Bladder Cancer
  • Kidney Cancer
  • Colorectal Cancer
  • Intestinal Cancer
  • Liver Cancer
  • Pancreatic Cancer
  • Stomach Cancer
  • Breast Cancer

If you are currently taking Zantac, you should discuss the potential risks – and alternative medication options – with your health care provider. There are multiple medication options that are approved for the same use.

Some case types may be handled with co-counsel.